Tokyo, Japan

Keiichi Hiramatsu

USPTO Granted Patents = 7 


 

Average Co-Inventor Count = 3.7

ph-index = 3

Forward Citations = 82(Granted Patents)


Location History:

  • Tokyo, JP (2000 - 2012)
  • Bunkyo-ku, JP (2017)

Company Filing History:


Years Active: 2000-2017

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Keiichi Hiramatsu: Innovator in Antibody Development

Introduction

Keiichi Hiramatsu is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of immunology, particularly in the development of antibodies for therapeutic applications. With a total of 7 patents, Hiramatsu's work addresses critical health issues, including staphylococcal infections.

Latest Patents

Hiramatsu's latest patents focus on providing an anti-antibody that has preventive or therapeutic effects on staphylococcal infections. The invention includes a method for manufacturing this antibody, as well as a composition, product, and drug containing it. The antibody is derived from deacetylated materials used for immunization. Another significant patent involves a toxin detection method, which provides an antibody against the Panton-Valentine leukocidin toxin. This method includes a kit for detecting the toxin and a pharmaceutical composition for treating infections caused by this toxin.

Career Highlights

Throughout his career, Keiichi Hiramatsu has worked with notable organizations, including Zenyaku Kogyo Kabushiki Kaisha and Juntendo University School of Medicine. His work in these institutions has allowed him to advance his research and contribute to the scientific community.

Collaborations

Hiramatsu has collaborated with esteemed colleagues such as Seiichiro Kawashima and Hideaki Hanaki. These partnerships have further enriched his research and development efforts in the field of immunology.

Conclusion

Keiichi Hiramatsu is a distinguished inventor whose work in antibody development has the potential to significantly impact the treatment of infections. His innovative approaches and collaborations continue to advance the field of immunology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…